Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrochlorothiazide add-on to olmesartan in uncontrolled moderate to severe hypertension
2006-003876-37Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of olmesartan and hydrochlorothiazide in essential hypertension (4 arms), sponsored by Daiichi Sankyo Co., Ltd. Started Oct 2006; status: completed.
02
Drugs
olmesartanhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2006-003876-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003876-37.